An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

Dangerously high levels of “bad” cholesterol and triglycerides may be reduced by gene editing, in what study researchers hope will be a “one and done” treatment.

By entering certain strings of numbers and symbols into your phone's dialer, you can gain access to a world of hidden ...